Prediction Model for 30-day Hospital Readmissions among Patients Discharged Receiving Outpatient Parenteral Antibiotic Therapy (OPAT).

Clinical Infectious Diseases (Impact Factor: 8.89). 12/2013; 58(6). DOI: 10.1093/cid/cit920
Source: PubMed


Factors associated with readmission for patients prescribed outpatient parenteral antibiotic therapy (OPAT) at hospital discharge have not been definitively identified. The study aim was to develop a model of 30-day readmissions for OPAT patients.

A database comprising 782 OPAT patients treated between 2009 and 2011 at a single academic center was created. Variables collected included patient demographics, comorbidities, infections, and antibiotic classes. Final model discrimination was assessed using the c-statistic, and calibration was examined graphically.

Mean patient age was 58 years (range, 18-95 years), 43% were women, and the most common diagnoses were bacteremia (24%), osteomyelitis (20%), and pyelonephritis (13%). The unplanned 30-day readmission rate was 26%. The leading indications for readmission were non-infection related (30%), worsening infection (29%), and new infection (19%). The final regression model consisted of age (odds ratio [OR], 1.09 per decade; 95% confidence interval [CI], 0.99-1.21), aminoglycoside use (OR, 2.33; 95% CI, 1.17-4.57), resistant organisms (OR, 1.57; 95% CI, 1.03-2.36), and number of prior hospital discharges without intravenous antibiotics in the past 12 months (OR, 1.20 per prior admission; 95% CI, 1.09-1.32). The c-statistic was 0.61 and the highest-risk quintile of patients had almost a 3-fold higher rate of readmission compared to the lowest.

Patients prescribed OPAT are at risk for readmission. A subgroup of patients at especially high risk can be identified using easily obtainable clinical characteristics at the time of hospital discharge. More intensive interventions to prevent OPAT readmissions should be targeted and tested with those at highest risk.

Download full-text


Available from: David R Snydman, Nov 19, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Outpatient parenteral antimicrobial therapy (OPAT) programs should strive to deliver safe, cost effective, and high quality care. One of the keys to developing and sustaining a high quality OPAT program is to understand the common challenges or barriers to OPAT delivery. We review the most common challenges to starting and managing an OPAT program and give practical advice on addressing these issues.
    Full-text · Article · Jun 2014 · Therapeutics and Clinical Risk Management
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fifteen years ago, only a small minority of hospital inpatients were considered suitable for outpatient parenteral antimicrobial therapy (OPAT) services ( Wiselka and Nicholson, 1997 ). Now, almost 70% of those treated with intravenous (IV) antibiotics as hospital inpatients are considered suitable ( Hitchcock et al, 2009 ). Around 38-53% of those requiring OPAT are able to self-administer (Hills et al, 2012). The demand for IV antimicrobial therapy is increasing and the way it is being delivered is changing. The delivery of IV anti-microbial therapy in the community has the potential to make a huge difference to the way health care is delivered. It can enable people who would once have been admitted to hospital to be treated in the community. It can facilitate early hospital discharge ( Nazarko, 2013a ). Potentially, there are huge benefits in developing OPAT but there are also risks. People may be subjected to an invasive treatment when it is not necessary; therapy may be continued when it is no longer necessary ( Nazarko, 2013b ; Conant et al, 2014 ); and patients may be selected for OPAT who would be best treated in hospital. The key to providing safe and effective care is to work together to maximise benefits and minimise risk ( Duncan et al, 2013 ). This article examines how acute and community services can work together to ensure appropriate selection, treatment and follow-up of patients.
    No preview · Article · Jul 2014 · British journal of nursing (Mark Allen Publishing)
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Outpatient parenteral antimicrobial therapy (OPAT) is the administration of antimicrobial therapy in the home or other non-acute care settings. A growing body of literature suggests OPAT is overused and oversight by antimicrobial stewardship programs (ASPs) can reduce overuse, reduce costs and improve patient safety. Our objective was to define the frequency and characteristics of OPAT use in a large VA medical center. Additionally, we aimed to assess the appropriateness of OPAT use and identify opportunities to improve OPAT use and patient safety. Methods: We conducted a retrospective chart review of OPAT episodes from January 1, 2012 to December 31, 2012 within the VA Salt Lake City Health System. Each episode was evaluated for drug(s) used, indication, duration of therapy, and if infectious diseases (ID) consultation was obtained. Each episode with and without ID consultation was assessed for appropriateness based on 6 potential modifications: stop therapy; IV to PO conversion; change in duration of therapy; change in drug; reduction in number of drugs; and change in dose. We determined whether a modification would have definitely, possibly or not been recommended for each category. Results: 193 OPAT episodes occurred in 148 patients. Eighty-one (42%) OPAT episodes were without ID consultation. The most frequently prescribed antimicrobials were vancomycin (34%), carbapenems (26%), 3rd generation cephalosporins (16%), and anti-pseudomonal penicillins (14%). The most common indications for OPAT were bone and joint infections (31%), urinary tract infections (UTIs) (24%) and skin and soft tissue infections (SSTIs) (17%). A definite modification would have been recommended in 35% of cases and a possible modification in 41% of cases. The most commonly recommended changes were IV to PO conversion (30%), change in duration (22%), and change in drug (22%). For 46% of cases, OPAT was potentially not indicated (16% stop, 30% IV to PO). Conclusion: We found a significant proportion of OPAT use at our institution was potentially avoidable. Misuse of OPAT is common with overuse of broad-spectrum antimicrobials and durations of therapy longer than guideline recommended. An antimicrobial stewardship intervention will likely improve the quality of OPAT use, reduce costs and improve patient safety.
    No preview · Conference Paper · Oct 2014
Show more